2021 annual financial data
Dare Bioscience 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -287.64%.
Operating income was -39,068,512 USD and net income was -38,696,105 USD.
Operating cash flow was -28,764,037 USD.
Get free Dare Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000,000 USD
- Operating income
- -39,068,512 USD
- Net income
- -38,696,105 USD
- Operating cash flow
- -28,764,037 USD